{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=13640&ordering=accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=13600&ordering=accession","results":[{"accession":"CLO:0012832","name":"GM02923 cell","definition":"[' NEURAMINIDASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0012833","name":"GM02922 cell","definition":"[' NEURAMINIDASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0012834","name":"GM02921 cell","definition":"[' NEURAMINIDASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0012835","name":"ND03142 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0012836","name":"ND03144 cell","definition":"[' EPILEPSY']","term_type":"cell line"},{"accession":"CLO:0012837","name":"ND03145 cell","definition":"[' EPILEPSY']","term_type":"cell line"},{"accession":"CLO:0012838","name":"ND03146 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0012839","name":"ND03136 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0012840","name":"ND03137 cell","definition":"[' NDPT031- AFRICAN AMERICAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0012841","name":"GM13355 cell","definition":"[' CEPH/UTAH PEDIGREE 1356']","term_type":"cell line"},{"accession":"CLO:0012842","name":"GM13356 cell","definition":"[' CEPH/VENEZUELAN PEDIGREE 104']","term_type":"cell line"},{"accession":"CLO:0012843","name":"GM13360 cell","definition":"[' MYOTUBULAR MYOPATHY 1; MTM1']","term_type":"cell line"},{"accession":"CLO:0012844","name":"GM13363 cell","definition":"[' CHARCOT-MARIE-TOOTH DISEASE 1B; CMT1B MYELIN PROTEIN ZERO; MPZ']","term_type":"cell line"},{"accession":"CLO:0012845","name":"GM13365 cell","definition":"[' ADRENAL HYPERPLASIA II']","term_type":"cell line"},{"accession":"CLO:0012846","name":"GM13370 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG']","term_type":"cell line"},{"accession":"CLO:0012847","name":"DA05574 cell","definition":"[' DIABETES MELLITUS FAMILY SAMPLE']","term_type":"cell line"},{"accession":"CLO:0012848","name":"GM17448 cell","definition":"[' SNP500 PANEL HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24']","term_type":"cell line"},{"accession":"CLO:0012849","name":"GM13395 cell","definition":"[' HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY']","term_type":"cell line"},{"accession":"CLO:0012850","name":"DA05575 cell","definition":"[' DIABETES MELLITUS FAMILY SAMPLE']","term_type":"cell line"},{"accession":"CLO:0012851","name":"GM13371 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG']","term_type":"cell line"}]}